Company / SG&A per Share
RIGEL PHARMACEUTICALS INC SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$6.54
FY2025
5-year range
$0.54 / $6.54
FY2021-FY2025
Trend
+1.2%
vs FY2024
Sector context
#26 of 210
Health Care
What the data says
RIGEL PHARMACEUTICALS INC's sg&a per share of $6.54 is higher than 88% of companies in the Health Care sector (FY2025). SG&A per Share has fluctuated over the past 10 years, ranging from $0.14 in FY2018 to $6.54 in FY2025.
Based on SEC 10-K filings.
6.54 in FY2025 with a 5-year CAGR of +70.4%. Top quartile in the Health Care sector.
Increased from $0.61 to $6.54 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +115.3%
- 5-Year CAGR
- +70.4%
- 10-Year CAGR
- -
Sector benchmark
-77.8% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 1.2% year-over-year.
- Ranks #26 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.54 | +1.2% |
| FY2024 | $6.47 | +960.5% |
| FY2023 | $0.61 | -6.9% |
| FY2022 | $0.66 | +20.7% |
| FY2021 | $0.54 | +19.0% |
| FY2020 | $0.46 | +2.2% |
| FY2019 | $0.45 | +213.3% |
| FY2018 | $0.14 | -52.4% |
| FY2017 | $0.30 | +35.2% |
| FY2016 | $0.22 | +10.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026